
European Growth Equities
DNCA Invest SRI Europe Growth
Growth
- Life insurance
- PEA

Key points
Conviction-based management based on a rigorous selection process
- Active and fundamental management invested in quality pan-European growth stocks.
- A selection of issuers based on 9 financial and non-financial criteria.
- A concentrated portfolio invests in companies that combine visible and sustainable growth.
Managers comments · October 2026
8 minutes
In line with previous months—and particularly since the start of the conflict in Iran—October brought its share of surprises, both on the macroeconomic and microeconomic fronts.
Ultimately, the FOMC meeting on October 28 had little real impact on the market, as no new guidance was provided (3.75% to 4.0%), despite a relatively hawkish tone from Kevin Warsh. This temporary status quo and the relative strength of the indices (-0.9% for the S&P, +2.0% for the Stoxx 600) partly reflect the robustness of the U.S. economy, with PMIs remaining in expansionary territory, as well as strong consumer resilience, combined with inflation that remains too high (U.S. core CPI +2.6% in September). To date, the market is anticipating another 25-basis-point hike in December.
In Europe, economic indicators remain more mixed, with a slight improvement in business sentiment in Germany but sluggish domestic growth. The ECB also opted to keep its key interest rates unchanged. Concerns about French public debt persist, as the government has been unable to pass its annual budget and appears incapable of taking adequate measures to reduce its deficit, estimated at around 5% of GDP. The 10-year OAT yield briefly exceeded 5%, and the spread with the 10-year German bond widened sharply, peaking at 165 bps at the end of the month—exceeding the all-time high set in 2011 (130 bps).
The resilience of the equity markets therefore seems surprising, given certain macroeconomic indicators. The price of a barrel of oil continues to soar ($118 for Brent) despite the resumption of oil flows through the Strait of Hormuz, and the U.S. 10-year yield is hovering around 5%. Heightened inflationary pressures appear to be persistent (conflict, sovereignty issues, reshoring, chip prices, etc.). Nevertheless, economic growth is showing resilience (+3.4% U.S. GDP in Q3 2026), thanks primarily to the explosion in investment in artificial intelligence (estimated to account for one-third of this growth), which is fueling a number of sectors (semiconductors, manufacturing, infrastructure), while generating significant wealth for certain Silicon Valley employees (see Antropic’s upcoming IPO) and in Korea (memory chip prices at record highs).
However, recent tensions surrounding the financing of Neocloud companies (Coreweave, Nebius), with particularly high interest rates (15%), prompt us to exercise caution, as do the U.S. midterm elections, which could put the brakes on this trend, potentially leading to more regulation governing the construction of data centers.
October thus saw a significant sector rotation in Europe, with a shift back toward defensive sectors: Health Care +14%, Consumer Discretionary +13%, and Insurance +7%, compared to -11% for Banks, for example. The technology sector ended the month with mixed results, featuring notable outperformance by companies perceived as “AI losers” (SAP, RELX…), at the expense of semiconductors, despite a string of impressive earnings reports during Q3.
ASML, in particular, announced that it would increase its EUV production capacity by 30% over the next two years, with the potential to reach 110 machines by 2028 (compared to 48 machines to be delivered in 2025). Demand is extremely robust and cannot be fully met. The company is also confident about its potential to raise prices and improve margins. That did not prevent the stock from closing the month down 11%. On the same theme, Schneider and Legrand also reported strong results.
Schneider’s new guidance (12–14% organic growth for 2026 vs. the initial 10–13%) appears almost conservative, given the triple-digit growth acceleration since the start of the year (+17% over 9 months), with demand driven by data centers. The stock fell 19% over the month. The announcement on October 5 of the $23 billion acquisition of industrial software publisher PTC weighed heavily on the stock and contributed significantly to the derating: the large size of the assets to be integrated, uncertainties regarding AI-related disruptions for a software company, and the need for significant financing through public markets (a €6 billion offering). Legrand raised its organic growth targets for the year (+11–13% versus +8–10% previously), thanks to strong performance in the U.S. data center sector.
Among industrial companies, Air Liquide performed well (+6%) following a convincing investor day, during which management presented the “Beyond 2030” medium-term plan: 5% annualized revenue growth, 10% annualized EPS growth, and a continued focus on profitability (a cumulative increase of 400 to 600 basis points). Its defensive profile is reassuring in the current environment, and Q3 results were solid (3% organic growth). By contrast, Safran was a major disappointment on the day of its earnings release (-10%). Rising oil prices and declining air traffic are not favorable for engine manufacturers. Operating performance, while still impressive, came in slightly below expectations (+13% at constant exchange rates, versus the consensus estimate of +14%), particularly for the key “civil aftermarket” metric in the Propulsion division (+18% vs. +21%). Admittedly, the comparison base was challenging. The slowdown itself justified a decline in the stock price. The unexpected announcement of an increase in the capital expenditure budget to 6% of sales (vs. 4.5% for the consensus, representing an increase of approximately one billion), without a clear explanation of its incremental contribution to growth, intensified selling pressure. Similarly, GTT fell 12% following its Q3 results (revenue down 13%), which were nevertheless expected to be minor. A cautious statement regarding a delay in ship deliveries in Q4 dissuaded management from raising its guidance. The departure of long-time Chairman Philippe Berterottiere, who played a key role in the company’s development, also weighed on sentiment.
On the positive side, the Norwegian group Kongsberg Gruppen, which specializes in missiles and air defense, stood out: it posted spectacular growth in revenue (+43% on a like-for-like basis) and operating income (+66%), while maintaining excellent momentum in new orders (+144%).
After several quarters marked by headwinds (post-COVID, President Trump’s election), the pharmaceutical sector has rebounded. Defensive characteristics, the prospect of a shift in the U.S. midterm elections, attractive valuations, and strong earnings reports contributed to the sector’s strong performance. UCB had a rather exceptional day, defying all expectations. An unexpected upward revision to guidance had already justified a rise of more than +10% in the stock price (revenue growth > 20% at constant exchange rates, EBITDA growth of +40% to +45% thanks to Bimzelx and Cimzia). Disappointing results released in the afternoon from Phase 3 trials of AbbVie’s competing drug, Lukizumab, for hidradenitis suppurativa (HS) allowed the stock to close up 22%, confirming the rebound that began earlier this month.
AstraZeneca has reassured investors following several disappointments and delays in its product pipeline. Strong profitability in Q3 and announcements of cost-cutting measures will improve the EPS outlook ($1.5 billion in savings). Galderma (+16% over the month) continues its impressive “beat and raise” trajectory across its entire portfolio, with annual growth forecasts raised to +22.5%/+23.5% (vs. +19%/21%), driven in particular by very strong performance from the drug Nemluvio (7% above expectations). In the same sector, L’Oréal surprised on the upside with solid organic growth in Q3 (+6.7% organic), confirming its ability to outperform the market. The professional division continues to accelerate (+14%), and the luxury division confirms its recovery (+7%), with China performing well (North Asia +8%).
NAV
As of 19/11/2026
Risk Indicator
Synthetic risk indicator according to PRIIPS. 1 corresponds to the lowest level and 7 to the highest level.
Risks
- Discretionary management risk
- Equity risk
- Liquidity risk
- Risk of capital loss
- Interest-rate risk
- Risk related to exchange rate
- Risk of investing in derivative instruments as well as instruments embedding derivatives
- Credit risk
- Counterparty risk
- Specific Risks linked to Convertible, Exchangeable and Mandatory Convertible Bonds
- ESG risk
- Sustainability risk
Performance and volatility
As of 19/11/2026
Past performance is not an indicator of future performance. Management fees are included in performance. The performances are calculated net of any fees by DNCA FINANCE. This is not a capital guarantee fund.
Breakdown by country
As of 30/09/2026
Performance
As of 19/11/2026
- Change of the name of the fund (formerly DNCA INVEST EUROPE GROWTH)
Past performance is not an indicator of future performance. Management fees are included in performance. The performances are calculated net of any fees by DNCA FINANCE. This is not a capital guarantee fund.
Portfolio Managers
Carl Auffret
European equity portfolio manager - CFA
Carl Auffret is a CFA* charterholder and also holds a master’s degree in Management and a postgraduate degree in Banking and Finance from Paris IX Dauphine University.
In 1999, he began his career at SG Securities in London as a sell-side analyst covering the consumer goods sector. In July 2003, he returned to France to become sector fund manager/analyst at CM-CIC Asset Management before taking over the Union Europe Growth pan-European growth equity fund in 2005.
He joined the DNCA Finance management team in May 2012.
*CFA® and Chartered Financial Analyst ® are registered trademarks of the CFA Institute.
Footnotes
* The inception date of the Fund is 28/12/2012.
Legal information
The above information is not a confirmation of any transaction and does not comprise investment advice. Past performances are not a reliable indicator of future performances. Management fees are included in performances. Access to products and services presented may be restricted regarding certain persons or countries. Tax treatment depends on the individual situation of each investor. For full information regarding strategies and fees, please refer to the prospectus, Key Information Document and other regulatory information available on this website or free of charge on demand from the investment management company’s registered offices.
You can access a summary of your rights here.
Information on the fees, commissions or non-monetary benefits : DNCA Finance would like to inform its clients (existing or potential) that within the context of its fund management business, DNCA Finance may receive from or pay to third parties (e.g. introducing brokers, distributors, brokers, asset managers) certain commissions, fees or non-monetary benefits in connection with the provision of investment or ancillary services. Upon request, DNCA Finance may communicate to its clients any additional information relating to these remunerations, commissions or non-monetary benefits.
The Sub-Fund promotes environmental and/or social characteristics within the meaning of Article 8 of SFDR.
Sustainability risk means an environmental, social, or governance event or condition that, if it occurs, could potentially or actually cause a material negative impact on the value of a Sub-Fund’s investment. Sustainability risks can either represent a risk of their own or have an impact on other risks and may contribute significantly to risks, such as market risks, operational risks, liquidity risks or counterparty risks. Sustainability risks may have an impact on long-term risk adjusted returns for investors. Assessment of sustainability risks is complex and may be based on environmental, social, or governance data which is difficult to obtain and incomplete, estimated, out of date or otherwise materially inaccurate. Even when identified, there can be no guarantee that these data will be correctly assessed.
Consequent impacts to the occurrence of sustainability risk can be many and varied according to a specific risk, region or asset class. Generally, when sustainability risk occurs for an asset, there will be a negative impact and potentially a total loss of its value and therefore an impact on the net asset value of the concerned Sub-Fund.
The reference benchmark does not intend to be consistent with the environmental or social characteristics promoted by the Sub-Fund.

